{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T01:43:21Z","timestamp":1772329401826,"version":"3.50.1"},"reference-count":24,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2025,3,31]]},"DOI":"10.1536\/ihj.24-744","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T22:07:49Z","timestamp":1743372469000},"page":"257-263","source":"Crossref","is-referenced-by-count":1,"title":["Coronary Microvascular Dysfunction and Adverse Outcomes in the Spectrum of Dilated Cardiomyopathy"],"prefix":"10.1536","volume":"66","author":[{"given":"Hisanori","family":"Kosuge","sequence":"first","affiliation":[{"name":"Department of Cardiology, Tokyo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatake","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Hachiya","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Hida","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Satomi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kitaoka H, Tsutsui H, Kubo T, <i>et al<\/i>. JCS\/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies. Circ J 2021; 85: 1590-689.","DOI":"10.1253\/circj.CJ-20-0910"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Puntmann VO, Voigt T, Chen Z, <i>et al<\/i>. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging 2013; 6: 475-84.","DOI":"10.1016\/j.jcmg.2012.08.019"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Rubi\u015b PP, Dziewi\u0119cka EM, Bany\u015b P, <i>et al<\/i>. Extracellular volume is an independent predictor of arrhythmic burden in dilated cardiomyopathy. Sci Rep 2021; 11: 24000.","DOI":"10.1038\/s41598-021-03452-z"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Petersen SE, Jerosch-Herold M, Hudsmith LE, <i>et al<\/i>. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation 2007; 115: 2418-25.","DOI":"10.1161\/CIRCULATIONAHA.106.657023"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Mandawat A, Chattranukulchai P, Mandawat A, <i>et al<\/i>. Progression of Myocardial Fibrosis in Nonischemic DCM and Association With Mortality and Heart Failure Outcomes. JACC Cardiovasc Imaging 2021; 14: 1338-50.","DOI":"10.1016\/j.jcmg.2020.11.006"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sobajima M, Nozawa T, Suzuki T, <i>et al<\/i>. Impact of myocardial perfusion abnormality on prognosis in patients with non-ischemic dilated cardiomyopathy. J Cardiol 2010; 56: 280-6.","DOI":"10.1016\/j.jjcc.2010.06.008"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kosuge H, Hachiya S, Fujita Y, <i>et al<\/i>. Potential of non-contrast stress T1 mapping for the assessment of myocardial injury in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 2023; 25: 53.","DOI":"10.1186\/s12968-023-00966-5"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Gulati A, Ismail TF, Ali A, <i>et al<\/i>. Microvascular Dysfunction in Dilated Cardiomyopathy: A Quantitative Stress Perfusion Cardiovascular Magnetic Resonance Study. JACC Cardiovasc Imaging 2019; 12: 1699-708.","DOI":"10.1016\/j.jcmg.2018.10.032"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kan A, Leng Y, Li S, <i>et al<\/i>. The predictive value of coronary microvascular dysfunction for left ventricular reverse remodelling in dilated cardiomyopathy. Front Cardiovasc Med 2023; 10: 1301509.","DOI":"10.3389\/fcvm.2023.1301509"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Pinto YM, Elliott PM, Arbustini E, <i>et al<\/i>. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J 2016; 37: 1850-8.","DOI":"10.1093\/eurheartj\/ehv727"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Orphanou N, Papatheodorou E, Anastasakis A. Dilated cardiomyopathy in the era of precision medicine: latest concepts and developments. Heart Fail Rev 2022; 27: 1173-91.","DOI":"10.1007\/s10741-021-10139-0"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Arbelo E, Protonotarios A, Gimeno JR, <i>et al<\/i>. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J 2023; 44: 3503-626.","DOI":"10.1093\/eurheartj\/ehad194"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Mombeini H, Parsaee M, Amin A. Speckle tracking echocardiography in hypokinetic non-dilated cardiomyopathy: comparison with dilated cardiomyopathy. ESC Heart Fail 2020; 7: 1909-16.","DOI":"10.1002\/ehf2.12764"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Verdonschot JAJ, Hazebroek MR, Wang P, <i>et al<\/i>. Clinical Phenotype and Genotype Associations With Improvement in Left Ventricular Function in Dilated Cardiomyopathy. Circ Heart Fail 2018; 11: e005220.","DOI":"10.1161\/CIRCHEARTFAILURE.118.005220"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Nakamori S, Sakuma H, Dohi K, <i>et al<\/i>. Combined Assessment of Stress Myocardial Perfusion Cardiovascular Magnetic Resonance and Flow Measurement in the Coronary Sinus Improves Prediction of Functionally Significant Coronary Stenosis Determined by Fractional Flow Reserve in Multivessel Disease. J Am Heart Assoc 2018; 7: e007736.","DOI":"10.1161\/JAHA.117.007736"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kitaoka H, Matsumura Y, Yamasaki N, <i>et al<\/i>. Long-term prognosis of patients with mildly dilated cardiomyopathy. Circ J 2002; 66: 557-60.","DOI":"10.1253\/circj.66.557"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Mewton N, Liu CY, Croisille P, <i>et al<\/i>. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 2011; 57: 891-903.","DOI":"10.1016\/j.jacc.2010.11.013"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Karamitsos TD, Arvanitaki A, Karvounis H, <i>et al<\/i>. Myocardial Tissue Characterization and Fibrosis by Imaging. JACC Cardiovasc Imaging 2020; 13: 1221-34.","DOI":"10.1016\/j.jcmg.2019.06.030"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Crea F, Camici PG, Bairey Merz CN. Coronary microvascular dysfunction: an update. Eur Heart J 2014; 35: 1101-11.","DOI":"10.1093\/eurheartj\/eht513"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kato S, Saito N, Nakachi T, <i>et al<\/i>. Stress Perfusion Coronary Flow Reserve Versus Cardiac Magnetic Resonance for Known or Suspected CAD. J Am Coll Cardiol 2017; 70: 869-79.","DOI":"10.1016\/j.jacc.2017.06.028"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Cecchi F, Olivotto I, Gistri R, <i>et al<\/i>. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2023; 349: 1027-35.","DOI":"10.1056\/NEJMoa025050"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Taqueti VR, Solomon SD, Shah AM, <i>et al<\/i>. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. Eur Heart J 2018; 39: 840-9.","DOI":"10.1093\/eurheartj\/ehx721"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Yang Z, Liu Y, Li Z, <i>et al<\/i>. Coronary microvascular dysfunction and cardiovascular disease: Pathogenesis, associations and treatment strategies. Biomed Pharmacother 2023; 164: 115011.","DOI":"10.1016\/j.biopha.2023.115011"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Mohammed SF, Hussain S, Mirzoyev SA, <i>et al<\/i>. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction. Circulation 2015; 131: 550-9.","DOI":"10.1161\/CIRCULATIONAHA.114.009625"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/66\/2\/66_24-744\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T03:52:27Z","timestamp":1743825147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/66\/2\/66_24-744\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.24-744","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,31]]},"article-number":"24-744"}}